Clinical trials

Risk for postpartum diabetes

About us

  • The Institute of Diabetes Research (IDF)

    The research focus of the Institute of Diabetes Research (Helmholtz Zentrum München) lays in the understanding of the natural history of type 1 diabetes, in the identification of mechanisms and predictive markers of the disease, and the translation of findings into trials to prevent type 1 diabetes in man. The lab is particularly interested in deciphering the molecular mechanisms of islet autoreactivity, and the interaction of environment, genes, and the immune response. The ultimate goal is the development of therapies for prevention and cure of islet autoaimmunity and diabetes. Another focus is to elucidate the impact of gestational diabetes and maternal hyperglycemia on the long term risk of obesity and type 2 diabetes in mother and offspring. The IDF is part of the Helmholtz Diabetes Center (HDC).


     

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.